Hong Kong reports 10 new COVID-19 cases, use of Fosun Pharma/BioNTech vaccine halted over packaging defects


HONG KONG, March 24 (Xinhua) — Hong Kong’s Center for Health Protection (CHP) reported 10 new confirmed cases of COVID-19 on Wednesday, taking its total tally to 11,419.

The new cases included four local infections, of which one was untraceable, according to the CHP. With one more infection found, the number of cases related to an outbreak in a fitness center in Western District rose to 151.

The Hong Kong Special Administrative Region (HKSAR) government on Wednesday suspended the vaccination of Fosun Pharma/BioNTech COVID-19 vaccine due to problems with their vial caps.

Some 403,000 Hong Kong residents have taken the first vaccine shot, with 150,200 of them given the Fosun Pharma/BioNTech vaccine.

The HKSAR government made the decision on receiving a written notice from Fosun Pharma, saying the packaging problem of the vaccines of batch number 210102 has been noticed.

German drug manufacturer BioNTech and Fosun Pharma are the developers of the vaccine.

BioNTech and Fosun Pharma said no safety risk was found in the product, but they called for an immediate suspension of the vaccination in the interest of prudence until an investigation is completed.

The HKSAR government said that all community vaccination centers will suspend the vaccination of the vaccine until further notice. Enditem


Leave A Reply